Skip to main content

Williams & Novak, LLC

SEC CIK
0001998419
Latest filing
Jul 8, 2026

The latest 13F from Williams & Novak, LLC covers Q2 2026 (filed Jul 8, 2026): 145 long positions worth $149.5M. The top 10 holdings make up 38.9% of the portfolio, and the largest is PIMCO Equity Ser at 6.7%. Livermore has 11 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
14
Est. +$3.58M
Added
56
Est. +$10.0M
Reduced
43
Est. −$5.22M
Sold out
11
Est. −$2.14M

Top 5 holdings

Share of this quarter's portfolio value

  1. PIMCO Equity Ser72202L363
    6.7%$10.0M
  2. Fidelity Merrimack STR Tr316188309
    6.2%$9.21M
  3. Fidelity Covington Trust316092113
    4.9%$7.39M
  4. PIMCO ETF Tr72201R585
    4.3%$6.42M
  5. SYPRSypris Solutions Inc
    3.6%$5.36MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. iShares Tr46434V266
    +$2.24MAdded
  2. Invesco Exchange Traded FD T46137V613
    +$1.23MAdded
  3. Amplify ETF Tr032108409
    +$653.8KAdded
  4. PIMCO ETF Tr72201R569
    +$544.3KAdded
  5. LLYEli Lilly & Co
    +$507.4KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Tr46434V266
    +1.33 pp1.9% → 3.2%
  2. MUMicron Technology Inc
    +0.87 pp0.5% → 1.3%History
  3. Invesco Exchange Traded FD T46137V613
    +0.82 pp0.2% → 1.0%
  4. LRCXLam Research Corp
    +0.50 pp0.7% → 1.2%History
  5. Amplify ETF Tr032108409
    +0.41 pp0.3% → 0.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Fidelity Merrimack STR Tr316188309
    −$1.52MReduced
  2. PIMCO ETF Tr72201R882
    −$608.8KReduced
  3. Invesco Exch TRD SLF Idx FD46138J619
    −$527.8KReduced
  4. NEENextera Energy Inc
    −$398.0KSold outHistory
  5. AVNSAvanos Medical, Inc.
    −$371.2KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Fidelity Merrimack STR Tr316188309
    −1.91 pp8.1% → 6.2%
  2. SLViShares Silver Trust
    −0.67 pp2.0% → 1.3%History
  3. PIMCO ETF Tr72201R882
    −0.50 pp1.0% → 0.5%
  4. PCQPIMCO California Municipal Income Fund
    −0.41 pp2.6% → 2.2%History
  5. PMLPIMCO Municipal Income Fund II
    −0.39 pp2.1% → 1.7%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$149.5M
+$16.2M (+12.1%) vs. prior quarter
Positions
145
+3 vs. prior quarter
Top 10 concentration
38.9%
Top 10 as share of value
Turnover
5.2%
Q2 2026, one quarter
Average holding period
9.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $149.5M (Q2 2026)

Q4 2023: $88.0MQ1 2024: $88.0MQ2 2024: $107.4MQ3 2024: $107.2MQ4 2024: $103.7MQ1 2025: $102.2MQ2 2025: $117.6MQ3 2025: $130.0MQ4 2025: $132.8MQ1 2026: $133.4MQ2 2026: $149.5M
Q4 2023Q2 2026
13F filings of Williams & Novak, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 8, 2026145$149.5MPIMCO Equity SerFidelity Merrimack STR TrFidelity Covington Trustvs. Q1 2026SEC
Q1 2026Apr 21, 2026142$133.4MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q4 2025SEC
Q4 2025Feb 5, 2026141$132.8MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q3 2025SEC
Q3 2025Oct 30, 2025140$130.0MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q2 2025SEC
Q2 2025Jul 24, 2025134$117.6MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q1 2025SEC
Q1 2025May 15, 2025127$102.2MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q4 2024SEC
Q4 2024Jan 23, 2025125$103.7MFidelity Merrimack STR TrPIMCO Equity SerFidelity Covington Trustvs. Q3 2024SEC
Q3 2024Oct 7, 2024129$107.2MFidelity Merrimack STR TrPIMCO Equity SerSYPRvs. Q2 2024SEC
Q2 2024Jul 12, 2024129$107.4MSYPRPIMCO Equity SerPIMCO ETF Trvs. Q1 2024SEC
Q1 2024Apr 16, 202488$88.0MSYPRPIMCO Equity SeriShares Trvs. Q4 2023SEC
Q4 2023Jan 26, 202491$88.0MSYPRPIMCO Equity SeriShares Tr–SEC

13D and 13G filings

Companies where Williams & Novak, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Williams & Novak, LLC does not currently report owning 5% or more of any company.

Latest filings

5 filings on file made by Williams & Novak, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Williams & Novak, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
SYPRSypris Solutions IncNov 4, 202413G/AOld format–––SEC
SYPRSypris Solutions IncSep 3, 202413G/AOld format–––SEC
SYPRSypris Solutions IncJan 23, 202413GOld format–––SEC
SYPRSypris Solutions IncJan 18, 202413G/AOld format–––SEC
SPYRSPYR, Inc.Oct 25, 202313GOld format–New–SEC